New dementia app brings together siblings, crosses disciplines

 'It puts everyone on the same page,' explained co-creator and McMaster alumna Alexis Liddell. 'We wanted an easier way to tap into the long term memories of individuals with dementia.'

McMaster graduates Alexis Liddell and Chris Benoit don't have a lot in common. She is a Humanities/Social Sciences graduate working in the long-term care field; he received his degree in Software Engineering and is working in mobile app development.

However, the two siblings have joined together on a project that is near and dear to both of them.

Inspired by their experiences visiting an aging relative in long-term care, the two developed an iPad designed to improve visits with loved ones living with .

Dubbed Promenade, the app was the brainchild of Liddell, who works with daily as a therapeutic recreationist. "Communicating with those we love is a daily struggle for so many sons and daughters of dementia sufferers," she explained. "Our hope is that Promenade can make visits more enjoyable for everyone involved."

Benoit took the idea and used his skills in software development to make it a reality. "Looking at the apps on the market today, we found there was a real gap in terms of communication tools, especially for seniors. Promenade is designed to fill that gap," he said.

The app combines high-resolution photos with sensory-based conversation questions in a way that makes it easier for those with dementia to reminisce about past life events and experiences.

A reminiscence therapy tool at its core, the app's photos provide the visual cue needed to help trigger the memories, and the questions provide an opportunity for the visiting family member or caregiver to help expand on that memory and discuss the details surrounding it.

"It puts everyone on the same page," explained Liddell. "We wanted an easier way to tap into the long term memories of individuals with dementia. These memories typically remain intact for a significantly longer period time than the short term. We want to utilize what's still there."

Their next step with the app is spreading the word. The duo have recently made presentations to the Alzheimer's Society, Mohawk College's Recreation and Leisure Services program and Hamilton/Niagara's Regional Family Council Network. They were also invited to present at the annual conferences for the Canadian Therapeutic Recreation Association (CTRA) and Therapeutic Recreation Ontario (TRO).

"We've been getting really positive feedback from users," Liddell said. "It's gratifying to see how our app can help turn around what can oftentimes be a frustrating or upsetting experience. It's all about seeing your loved one engaged again."

With the app now launched, the pair have added another cross-disciplinary piece into the mix. Liddell's husband Ryan, a graduate of the DeGroote School of Business and a current employee in the Faculty of Health Sciences, has been assisting with the development and promotion of Promenade. "I'm proud to be able to play a small part in this. They've created a great product, so that makes it easier when it comes to promotion," he said.

Promenade is available through the Apple App Store and is compatible with any iPad that runs iOS7.

add to favorites email to friend print save as pdf

Related Stories

New app widens opportunities for dementia assessments

Jul 09, 2014

A team of clinicians from Plymouth, UK, and Sydney, Australia, have today (Wednesday 9th July 2014 UK, Thursday 10th July Australia) launched ACEmobile - a free-to-use app to support the assessment of dementia, ...

Facebook slings new photo/video messaging app

Jun 17, 2014

Facebook released Tuesday a new instant messaging app that enables users to send photos or video to selected friends who can only see them if they send an image back.

Recommended for you

New technique could benefit Alzheimer's diagnosis

Sep 01, 2014

Swinburne researchers have developed a technique to create a highly sensitive surface for measuring the concentration of a peptide that is a biomarker for early stage Alzheimer's disease.

User comments